Topic overview
In brief
- Spider-Man: Brand New Day achieved $360 million in ticket sales during its opening weekend in North America.
- This surpassed the previous record held by Avengers: Endgame, which opened with $357 million.
- The film's success reflects a significant recovery in the box office amid the pandemic.
Summary
In a remarkable turn of events, the film industry witnessed a significant milestone when Spider-Man: Brand New Day achieved a record-breaking opening weekend in North America. This event took place in early January 2022, as the film garnered an impressive $360 million in ticket sales across theaters in the United States and Canada. The success of this film not only surpassed the previous record held by Avengers: Endgame, which had opened with $357 million in 2019, but also marked a new high for the domestic box office. Prior to this, no film had ever opened with over $300 million domestically, with the previous record holders being Avengers: Infinity War and Star Wars: The Force Awakens, which opened with $257 million and $247 million, respectively. The achievement of Spider-Man: Brand New Day is particularly noteworthy given the context of the ongoing pandemic, which has significantly impacted the film industry. The film's strong performance was bolstered by a robust marketing campaign and the star power of Tom Holland, Zendaya, and Jon Bernthal, who also appeared in another high-grossing film, The Odyssey. This combination of factors contributed to a record weekend overall for movie theaters in the U.S. and Canada, with the domestic box office up over 15% from the previous year, totaling over $6.2 billion in ticket sales to date. Tom Rothman, the chairman and CEO of Sony Pictures Motion Picture Group, expressed pride in this achievement, stating that records are made to be broken, but they will take great pride in holding this one for as long as possible. The success of Spider-Man: Brand New Day not only highlights the resilience of the film industry during challenging times but also sets a new benchmark for future releases, indicating a potential resurgence in box office performance as audiences return to theaters.
